20-176 - Traditional Versus Early Aggressive Therapy for Multiple Sclerosis TrialStatus: open
A Pragmatic Trial to Evaluate the Intermediate-term Effects of Early, Aggressive Versus Escalation Therapy in People With Multiple Sclerosis
This is a randomized trial for multiple sclerosis. The purpose is to evaluate disability risk between early aggressive therapy and traditional first-line therapy. Subject will be randomized to receive one of the two treatment types and will be evaluated over a 4 year period.